| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 85 | 2024 | 2118 | 8.250 |
Why?
|
| Radiology Department, Hospital | 37 | 2020 | 409 | 4.510 |
Why?
|
| Diagnostic Imaging | 50 | 2017 | 3543 | 3.280 |
Why?
|
| Radiology Information Systems | 18 | 2016 | 533 | 2.180 |
Why?
|
| Leadership | 12 | 2024 | 1395 | 1.970 |
Why?
|
| Tomography, Spiral Computed | 12 | 2005 | 274 | 1.880 |
Why?
|
| Societies, Medical | 16 | 2015 | 3955 | 1.640 |
Why?
|
| Organizational Objectives | 7 | 2012 | 427 | 1.560 |
Why?
|
| Tomography, X-Ray Computed | 53 | 2019 | 20762 | 1.450 |
Why?
|
| Medical Order Entry Systems | 6 | 2017 | 522 | 1.420 |
Why?
|
| Radiography, Abdominal | 6 | 2012 | 541 | 1.280 |
Why?
|
| Academic Medical Centers | 16 | 2015 | 2785 | 1.090 |
Why?
|
| Teleradiology | 6 | 2016 | 52 | 1.070 |
Why?
|
| Decision Support Systems, Clinical | 6 | 2017 | 1176 | 1.070 |
Why?
|
| Practice Management, Medical | 6 | 2020 | 191 | 1.010 |
Why?
|
| Marketing of Health Services | 3 | 2020 | 151 | 0.910 |
Why?
|
| Attitude of Health Personnel | 15 | 2010 | 3922 | 0.890 |
Why?
|
| Artificial Intelligence | 4 | 2024 | 2659 | 0.870 |
Why?
|
| Radiographic Image Enhancement | 10 | 2013 | 878 | 0.870 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2015 | 395 | 0.820 |
Why?
|
| Efficiency, Organizational | 11 | 2015 | 699 | 0.800 |
Why?
|
| Radiation Dosage | 15 | 2012 | 1973 | 0.790 |
Why?
|
| Models, Organizational | 6 | 2013 | 546 | 0.780 |
Why?
|
| Delivery of Health Care | 11 | 2023 | 5367 | 0.780 |
Why?
|
| Health Care Reform | 7 | 2010 | 1256 | 0.760 |
Why?
|
| Accidental Falls | 3 | 2015 | 1081 | 0.760 |
Why?
|
| Capital Expenditures | 4 | 2012 | 27 | 0.760 |
Why?
|
| Internationality | 5 | 2015 | 1007 | 0.750 |
Why?
|
| Outpatients | 4 | 2017 | 1607 | 0.730 |
Why?
|
| Health Services Misuse | 2 | 2017 | 249 | 0.730 |
Why?
|
| Faculty | 1 | 2023 | 384 | 0.690 |
Why?
|
| Radiography | 20 | 2023 | 6995 | 0.680 |
Why?
|
| United States | 88 | 2020 | 73121 | 0.670 |
Why?
|
| Contract Services | 4 | 2008 | 90 | 0.650 |
Why?
|
| Lobbying | 3 | 2010 | 32 | 0.650 |
Why?
|
| Radionuclide Imaging | 84 | 2004 | 1998 | 0.650 |
Why?
|
| Radiation Protection | 7 | 2012 | 428 | 0.630 |
Why?
|
| Tomography, Emission-Computed | 18 | 2005 | 1123 | 0.630 |
Why?
|
| Quality Assurance, Health Care | 12 | 2015 | 2179 | 0.620 |
Why?
|
| Referral and Consultation | 9 | 2011 | 3629 | 0.610 |
Why?
|
| Hospital-Physician Relations | 2 | 2008 | 17 | 0.600 |
Why?
|
| Administrative Personnel | 1 | 2019 | 185 | 0.600 |
Why?
|
| Radiography, Thoracic | 5 | 2019 | 1320 | 0.590 |
Why?
|
| Interinstitutional Relations | 2 | 2009 | 236 | 0.580 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2012 | 172 | 0.570 |
Why?
|
| Biotechnology | 2 | 2009 | 282 | 0.570 |
Why?
|
| Private Practice | 2 | 2008 | 155 | 0.560 |
Why?
|
| Public Opinion | 2 | 2013 | 487 | 0.560 |
Why?
|
| Technetium | 45 | 1985 | 326 | 0.530 |
Why?
|
| Insurance, Health, Reimbursement | 5 | 2010 | 389 | 0.520 |
Why?
|
| Professional Competence | 3 | 2010 | 431 | 0.490 |
Why?
|
| Advisory Committees | 2 | 2010 | 797 | 0.490 |
Why?
|
| Hospital Administration | 2 | 2009 | 353 | 0.480 |
Why?
|
| Colitis, Ischemic | 1 | 2015 | 32 | 0.480 |
Why?
|
| Utilization Review | 7 | 2015 | 384 | 0.470 |
Why?
|
| Health Care Sector | 2 | 2008 | 196 | 0.470 |
Why?
|
| Physician Self-Referral | 4 | 2010 | 18 | 0.460 |
Why?
|
| Technology, Radiologic | 7 | 2004 | 160 | 0.460 |
Why?
|
| Practice Guidelines as Topic | 16 | 2015 | 7451 | 0.430 |
Why?
|
| Health Facility Planning | 1 | 2012 | 19 | 0.420 |
Why?
|
| Humans | 254 | 2024 | 768451 | 0.420 |
Why?
|
| Health Promotion | 2 | 2015 | 2215 | 0.410 |
Why?
|
| Politics | 2 | 2009 | 821 | 0.390 |
Why?
|
| Science | 3 | 2010 | 239 | 0.390 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 2518 | 0.390 |
Why?
|
| Efficiency | 5 | 2013 | 477 | 0.390 |
Why?
|
| Information Dissemination | 3 | 2015 | 1138 | 0.390 |
Why?
|
| Data Mining | 2 | 2015 | 561 | 0.380 |
Why?
|
| Knowledge | 1 | 2013 | 178 | 0.380 |
Why?
|
| Risk Management | 2 | 2014 | 558 | 0.370 |
Why?
|
| Technology Assessment, Biomedical | 7 | 2009 | 308 | 0.370 |
Why?
|
| Forecasting | 14 | 2018 | 2950 | 0.370 |
Why?
|
| Health Care Rationing | 2 | 2011 | 436 | 0.370 |
Why?
|
| Mammography | 6 | 2021 | 2436 | 0.370 |
Why?
|
| Interprofessional Relations | 6 | 2009 | 997 | 0.360 |
Why?
|
| Faculty, Medical | 3 | 2023 | 1218 | 0.360 |
Why?
|
| Molecular Probe Techniques | 2 | 2009 | 111 | 0.360 |
Why?
|
| Diagnostic Errors | 2 | 2015 | 1282 | 0.360 |
Why?
|
| Health Care Costs | 7 | 2011 | 3265 | 0.360 |
Why?
|
| Diffusion of Innovation | 3 | 2013 | 730 | 0.360 |
Why?
|
| International Cooperation | 4 | 2012 | 1439 | 0.360 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2011 | 96 | 0.350 |
Why?
|
| Defensive Medicine | 2 | 2010 | 47 | 0.350 |
Why?
|
| Practice Management | 2 | 2020 | 37 | 0.350 |
Why?
|
| Biomedical Research | 9 | 2015 | 3463 | 0.350 |
Why?
|
| Federal Government | 2 | 2008 | 266 | 0.340 |
Why?
|
| Physician-Patient Relations | 3 | 2013 | 3267 | 0.330 |
Why?
|
| User-Computer Interface | 3 | 2010 | 1397 | 0.330 |
Why?
|
| Medical Records Systems, Computerized | 3 | 2000 | 1193 | 0.320 |
Why?
|
| Evidence-Based Medicine | 4 | 2010 | 3708 | 0.320 |
Why?
|
| Physicians | 4 | 2013 | 4615 | 0.320 |
Why?
|
| Medicare | 5 | 2011 | 6881 | 0.320 |
Why?
|
| Research | 3 | 2007 | 1984 | 0.320 |
Why?
|
| Physician's Role | 3 | 2011 | 927 | 0.310 |
Why?
|
| Group Practice | 1 | 2009 | 151 | 0.310 |
Why?
|
| Radiology, Interventional | 3 | 2013 | 477 | 0.300 |
Why?
|
| Allied Health Personnel | 2 | 2006 | 156 | 0.300 |
Why?
|
| Radiation Injuries | 3 | 2011 | 1205 | 0.300 |
Why?
|
| Contracts | 1 | 2008 | 60 | 0.290 |
Why?
|
| Fee-for-Service Plans | 2 | 2010 | 714 | 0.290 |
Why?
|
| Technology Transfer | 1 | 2007 | 42 | 0.280 |
Why?
|
| Massachusetts | 13 | 2020 | 8908 | 0.280 |
Why?
|
| Positron-Emission Tomography | 6 | 2015 | 6657 | 0.280 |
Why?
|
| Community-Institutional Relations | 1 | 2008 | 208 | 0.270 |
Why?
|
| Fluorodeoxyglucose F18 | 5 | 2015 | 2048 | 0.270 |
Why?
|
| Financial Management | 3 | 2003 | 161 | 0.270 |
Why?
|
| Workload | 3 | 2011 | 852 | 0.270 |
Why?
|
| Computer Communication Networks | 2 | 1999 | 295 | 0.270 |
Why?
|
| Negotiating | 1 | 2008 | 152 | 0.270 |
Why?
|
| Radioisotopes | 16 | 1991 | 516 | 0.270 |
Why?
|
| Safety | 3 | 2007 | 1159 | 0.270 |
Why?
|
| Research Support as Topic | 7 | 2010 | 699 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 12 | 2016 | 9066 | 0.260 |
Why?
|
| Reimbursement Mechanisms | 4 | 2017 | 677 | 0.260 |
Why?
|
| Quality of Health Care | 6 | 2007 | 4340 | 0.260 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2012 | 1226 | 0.260 |
Why?
|
| Technology, High-Cost | 2 | 2009 | 32 | 0.260 |
Why?
|
| Program Development | 2 | 2024 | 1296 | 0.260 |
Why?
|
| Biomedical Engineering | 1 | 2007 | 286 | 0.250 |
Why?
|
| Economic Competition | 2 | 2004 | 223 | 0.250 |
Why?
|
| Workplace | 2 | 2023 | 872 | 0.250 |
Why?
|
| Pelvis | 1 | 2010 | 737 | 0.250 |
Why?
|
| Facility Design and Construction | 1 | 2005 | 85 | 0.250 |
Why?
|
| Resource Allocation | 2 | 2004 | 353 | 0.240 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2007 | 281 | 0.240 |
Why?
|
| Data Collection | 11 | 2004 | 3329 | 0.240 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2009 | 952 | 0.240 |
Why?
|
| Patients | 1 | 2011 | 909 | 0.240 |
Why?
|
| Health Occupations | 1 | 2006 | 225 | 0.230 |
Why?
|
| Malpractice | 1 | 2009 | 561 | 0.230 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2004 | 146 | 0.230 |
Why?
|
| Cost Control | 8 | 2017 | 627 | 0.220 |
Why?
|
| Appointments and Schedules | 2 | 2007 | 443 | 0.220 |
Why?
|
| Radiometry | 4 | 2011 | 816 | 0.210 |
Why?
|
| Hospital Departments | 3 | 1989 | 135 | 0.210 |
Why?
|
| Purchasing, Hospital | 3 | 1994 | 14 | 0.210 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 1120 | 0.210 |
Why?
|
| Molecular Biology | 4 | 2007 | 573 | 0.210 |
Why?
|
| Medical Oncology | 1 | 2015 | 2347 | 0.210 |
Why?
|
| Hamartoma | 1 | 2005 | 236 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2017 | 36840 | 0.210 |
Why?
|
| Managed Care Programs | 5 | 2005 | 941 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2006 | 497 | 0.200 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 1207 | 0.200 |
Why?
|
| Staff Development | 1 | 2024 | 230 | 0.200 |
Why?
|
| Remote Consultation | 1 | 2005 | 242 | 0.200 |
Why?
|
| Contrast Media | 11 | 2016 | 5336 | 0.200 |
Why?
|
| Telemedicine | 4 | 2007 | 3104 | 0.190 |
Why?
|
| Image Enhancement | 7 | 2010 | 2894 | 0.190 |
Why?
|
| Health Services | 2 | 2004 | 756 | 0.190 |
Why?
|
| Genetics, Medical | 1 | 2004 | 334 | 0.190 |
Why?
|
| Organizational Case Studies | 2 | 2020 | 301 | 0.180 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2011 | 1252 | 0.180 |
Why?
|
| Thallium | 10 | 1983 | 100 | 0.180 |
Why?
|
| Ambulatory Care | 2 | 2014 | 2780 | 0.180 |
Why?
|
| Boston | 8 | 2015 | 9361 | 0.180 |
Why?
|
| Neoplasms | 6 | 2015 | 22386 | 0.180 |
Why?
|
| Health Services Needs and Demand | 2 | 2007 | 1408 | 0.180 |
Why?
|
| Primary Health Care | 1 | 2017 | 4737 | 0.180 |
Why?
|
| Communication | 3 | 2010 | 3910 | 0.170 |
Why?
|
| Emergency Medical Services | 2 | 2015 | 1948 | 0.170 |
Why?
|
| Education, Medical, Graduate | 2 | 2010 | 2411 | 0.170 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.170 |
Why?
|
| Awareness | 1 | 2004 | 654 | 0.170 |
Why?
|
| Female | 76 | 2023 | 396943 | 0.170 |
Why?
|
| Systems Integration | 3 | 2009 | 429 | 0.170 |
Why?
|
| Costs and Cost Analysis | 8 | 2005 | 1670 | 0.170 |
Why?
|
| Models, Economic | 3 | 2010 | 717 | 0.170 |
Why?
|
| Computer Systems | 3 | 2012 | 470 | 0.160 |
Why?
|
| Ultrasonography | 8 | 2008 | 5995 | 0.160 |
Why?
|
| Genomics | 1 | 2015 | 5909 | 0.160 |
Why?
|
| Risk Assessment | 10 | 2020 | 24311 | 0.160 |
Why?
|
| Health Expenditures | 1 | 2011 | 2391 | 0.160 |
Why?
|
| Hydronephrosis | 6 | 2002 | 274 | 0.160 |
Why?
|
| Program Evaluation | 2 | 2020 | 2508 | 0.160 |
Why?
|
| Nuclear Medicine | 3 | 2003 | 259 | 0.150 |
Why?
|
| Information Storage and Retrieval | 2 | 2005 | 823 | 0.150 |
Why?
|
| Automation | 2 | 2011 | 588 | 0.150 |
Why?
|
| Nanotechnology | 1 | 2004 | 714 | 0.150 |
Why?
|
| Male | 77 | 2020 | 364781 | 0.150 |
Why?
|
| Organizational Innovation | 2 | 2013 | 540 | 0.150 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2009 | 100 | 0.150 |
Why?
|
| Angiography | 7 | 2008 | 1598 | 0.140 |
Why?
|
| Life Style | 1 | 2009 | 3929 | 0.140 |
Why?
|
| Mass Screening | 3 | 2010 | 5455 | 0.140 |
Why?
|
| Medicine | 4 | 2010 | 946 | 0.140 |
Why?
|
| Inservice Training | 1 | 2000 | 377 | 0.140 |
Why?
|
| Personnel Selection | 1 | 2019 | 201 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 1468 | 0.140 |
Why?
|
| Decision Making | 3 | 2009 | 3961 | 0.140 |
Why?
|
| Acute Disease | 4 | 2008 | 7246 | 0.130 |
Why?
|
| Health Facility Merger | 1 | 1997 | 47 | 0.130 |
Why?
|
| Internet | 2 | 2006 | 3123 | 0.130 |
Why?
|
| Time Management | 3 | 2005 | 52 | 0.130 |
Why?
|
| Clinical Competence | 3 | 2013 | 4841 | 0.130 |
Why?
|
| Voice | 1 | 1999 | 268 | 0.130 |
Why?
|
| Pneumothorax | 1 | 2019 | 393 | 0.130 |
Why?
|
| Liver Neoplasms | 11 | 2011 | 4362 | 0.130 |
Why?
|
| Uncertainty | 2 | 2011 | 758 | 0.130 |
Why?
|
| Adrenal Gland Neoplasms | 5 | 2011 | 736 | 0.130 |
Why?
|
| Decision Support Techniques | 3 | 2013 | 2010 | 0.120 |
Why?
|
| Pharmacy Service, Hospital | 2 | 1987 | 134 | 0.120 |
Why?
|
| History, 21st Century | 3 | 2015 | 1575 | 0.120 |
Why?
|
| Mentors | 1 | 2020 | 672 | 0.120 |
Why?
|
| Sensitivity and Specificity | 11 | 2019 | 14728 | 0.120 |
Why?
|
| Peer Group | 1 | 2020 | 697 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 2062 | 0.120 |
Why?
|
| Thyroid Diseases | 5 | 1989 | 388 | 0.120 |
Why?
|
| Colonography, Computed Tomographic | 2 | 2007 | 170 | 0.120 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 59680 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2643 | 0.120 |
Why?
|
| History, 19th Century | 2 | 2007 | 716 | 0.110 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2014 | 101 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2009 | 4533 | 0.110 |
Why?
|
| Iodine Radioisotopes | 11 | 1984 | 1035 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2000 | 959 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 18048 | 0.110 |
Why?
|
| Radioisotope Renography | 6 | 2002 | 61 | 0.110 |
Why?
|
| Patient Care | 1 | 1999 | 629 | 0.110 |
Why?
|
| Carcinoma | 1 | 2005 | 2341 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 7 | 2010 | 5532 | 0.110 |
Why?
|
| Specialization | 2 | 2004 | 782 | 0.110 |
Why?
|
| Peer Review, Health Care | 1 | 2013 | 73 | 0.110 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 285 | 0.110 |
Why?
|
| Employee Performance Appraisal | 1 | 2013 | 86 | 0.110 |
Why?
|
| Registries | 1 | 2009 | 8373 | 0.110 |
Why?
|
| Europe | 3 | 2017 | 3439 | 0.110 |
Why?
|
| Ureteral Obstruction | 5 | 2002 | 297 | 0.110 |
Why?
|
| Coronary Angiography | 7 | 2009 | 4526 | 0.100 |
Why?
|
| Middle Aged | 51 | 2019 | 223418 | 0.100 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 365 | 0.100 |
Why?
|
| Deoxyglucose | 1 | 1993 | 333 | 0.100 |
Why?
|
| Observer Variation | 3 | 2010 | 2622 | 0.100 |
Why?
|
| Algorithms | 3 | 2012 | 14158 | 0.100 |
Why?
|
| X-Ray Film | 2 | 2004 | 31 | 0.100 |
Why?
|
| Heart | 17 | 1989 | 4451 | 0.100 |
Why?
|
| Health Personnel | 1 | 2006 | 3384 | 0.100 |
Why?
|
| Pulmonary Embolism | 8 | 2006 | 2591 | 0.100 |
Why?
|
| Medical Staff, Hospital | 1 | 1996 | 603 | 0.100 |
Why?
|
| Health Resources | 2 | 2011 | 950 | 0.100 |
Why?
|
| Burnout, Professional | 1 | 2021 | 712 | 0.100 |
Why?
|
| Abdominal Neoplasms | 1 | 1993 | 287 | 0.100 |
Why?
|
| Head | 2 | 2011 | 927 | 0.100 |
Why?
|
| Coronary Disease | 13 | 1984 | 5926 | 0.100 |
Why?
|
| Pelvic Neoplasms | 1 | 1993 | 250 | 0.090 |
Why?
|
| Genome, Human | 1 | 2004 | 4453 | 0.090 |
Why?
|
| Body Burden | 1 | 2011 | 158 | 0.090 |
Why?
|
| Renal Colic | 1 | 2011 | 29 | 0.090 |
Why?
|
| Radiography, Interventional | 3 | 2010 | 1127 | 0.090 |
Why?
|
| Incidence | 3 | 2020 | 21552 | 0.090 |
Why?
|
| Serum Albumin | 9 | 1984 | 676 | 0.090 |
Why?
|
| Accreditation | 3 | 2010 | 478 | 0.090 |
Why?
|
| Physicians, Primary Care | 1 | 2017 | 621 | 0.090 |
Why?
|
| Bone Diseases | 5 | 1989 | 418 | 0.090 |
Why?
|
| Retrospective Studies | 12 | 2018 | 81834 | 0.090 |
Why?
|
| Spleen | 1 | 2016 | 2298 | 0.090 |
Why?
|
| Relative Value Scales | 2 | 2000 | 86 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2005 | 9382 | 0.090 |
Why?
|
| Lymphography | 2 | 1989 | 189 | 0.080 |
Why?
|
| Aged | 35 | 2019 | 171520 | 0.080 |
Why?
|
| Planning Techniques | 3 | 1994 | 82 | 0.080 |
Why?
|
| Drug Design | 2 | 2005 | 1050 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 813 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2014 | 2286 | 0.080 |
Why?
|
| Child, Preschool | 11 | 2019 | 42623 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2007 | 5510 | 0.080 |
Why?
|
| Trauma Centers | 1 | 2015 | 950 | 0.080 |
Why?
|
| Case Management | 1 | 2011 | 276 | 0.080 |
Why?
|
| Professional Practice | 1 | 2011 | 314 | 0.080 |
Why?
|
| Hospitals, General | 3 | 2000 | 807 | 0.080 |
Why?
|
| Radiopharmaceuticals | 5 | 2015 | 2731 | 0.080 |
Why?
|
| Hospital Bed Capacity, 500 and over | 4 | 1992 | 113 | 0.080 |
Why?
|
| Age Distribution | 1 | 2014 | 2881 | 0.080 |
Why?
|
| Kidney Neoplasms | 3 | 2011 | 4298 | 0.080 |
Why?
|
| Data Display | 2 | 2000 | 174 | 0.080 |
Why?
|
| Adolescent | 19 | 2019 | 89168 | 0.080 |
Why?
|
| Injections, Intra-Articular | 1 | 2009 | 288 | 0.080 |
Why?
|
| Diagnosis-Related Groups | 1 | 2010 | 448 | 0.080 |
Why?
|
| Adrenal Glands | 8 | 1984 | 557 | 0.080 |
Why?
|
| Uterine Diseases | 1 | 2008 | 108 | 0.070 |
Why?
|
| Nephrolithiasis | 1 | 2009 | 117 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2011 | 993 | 0.070 |
Why?
|
| Outsourced Services | 1 | 2007 | 20 | 0.070 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 11 | 1993 | 66 | 0.070 |
Why?
|
| Sex Factors | 3 | 2017 | 10647 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3438 | 0.070 |
Why?
|
| Economics | 1 | 2008 | 141 | 0.070 |
Why?
|
| Young Adult | 6 | 2019 | 60045 | 0.070 |
Why?
|
| Phosphates | 3 | 1976 | 767 | 0.070 |
Why?
|
| Software | 4 | 2013 | 4463 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1993 | 1376 | 0.070 |
Why?
|
| Uterine Hemorrhage | 1 | 2008 | 240 | 0.070 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 2665 | 0.070 |
Why?
|
| Ureter | 5 | 1983 | 370 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2011 | 435 | 0.070 |
Why?
|
| Documentation | 2 | 2011 | 913 | 0.070 |
Why?
|
| Iodine | 3 | 1978 | 287 | 0.070 |
Why?
|
| Colic | 1 | 2006 | 44 | 0.070 |
Why?
|
| Adult | 47 | 2019 | 223542 | 0.070 |
Why?
|
| Cardiac Output | 6 | 1982 | 838 | 0.070 |
Why?
|
| Cerebral Angiography | 2 | 2010 | 1282 | 0.070 |
Why?
|
| Bile Duct Diseases | 1 | 2007 | 98 | 0.070 |
Why?
|
| Fluorescence | 4 | 1978 | 760 | 0.070 |
Why?
|
| Ablation Techniques | 1 | 2009 | 249 | 0.070 |
Why?
|
| Pamphlets | 1 | 1986 | 71 | 0.070 |
Why?
|
| Equipment Design | 2 | 2004 | 3530 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3230 | 0.070 |
Why?
|
| Heart Diseases | 4 | 1980 | 2816 | 0.070 |
Why?
|
| Bone Neoplasms | 9 | 1989 | 2562 | 0.070 |
Why?
|
| Ships | 1 | 2006 | 53 | 0.070 |
Why?
|
| History, 20th Century | 3 | 2015 | 2772 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2011 | 699 | 0.060 |
Why?
|
| Medical Records | 1 | 2011 | 1413 | 0.060 |
Why?
|
| Safety Management | 2 | 2011 | 764 | 0.060 |
Why?
|
| Job Description | 1 | 2005 | 61 | 0.060 |
Why?
|
| Breast Neoplasms | 5 | 2010 | 21156 | 0.060 |
Why?
|
| Bile Ducts | 1 | 2007 | 288 | 0.060 |
Why?
|
| Arthralgia | 1 | 2009 | 462 | 0.060 |
Why?
|
| False Negative Reactions | 4 | 2004 | 575 | 0.060 |
Why?
|
| Hospital-Physician Joint Ventures | 2 | 1996 | 31 | 0.060 |
Why?
|
| False Positive Reactions | 3 | 2004 | 962 | 0.060 |
Why?
|
| Risk Factors | 10 | 2014 | 74915 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2011 | 8730 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2012 | 825 | 0.060 |
Why?
|
| Hematuria | 1 | 2006 | 233 | 0.060 |
Why?
|
| Child | 16 | 2019 | 80863 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2008 | 959 | 0.060 |
Why?
|
| Pancreatic Cyst | 1 | 2009 | 369 | 0.060 |
Why?
|
| Social Values | 1 | 2006 | 225 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2012 | 737 | 0.060 |
Why?
|
| Pancreatic Ducts | 1 | 2007 | 330 | 0.060 |
Why?
|
| Financing, Government | 1 | 2008 | 473 | 0.060 |
Why?
|
| Infusions, Intra-Arterial | 8 | 1986 | 221 | 0.060 |
Why?
|
| Competency-Based Education | 1 | 2006 | 224 | 0.060 |
Why?
|
| Consensus | 2 | 2013 | 3207 | 0.060 |
Why?
|
| Computers | 5 | 1985 | 592 | 0.060 |
Why?
|
| Pancreatic Diseases | 1 | 2007 | 353 | 0.060 |
Why?
|
| Physical Exertion | 8 | 1982 | 669 | 0.060 |
Why?
|
| Pharmacists | 1 | 1987 | 261 | 0.060 |
Why?
|
| Steroids | 1 | 2009 | 937 | 0.060 |
Why?
|
| Indium | 3 | 1983 | 47 | 0.060 |
Why?
|
| Medical Informatics Applications | 1 | 2006 | 180 | 0.060 |
Why?
|
| Robotics | 1 | 2011 | 826 | 0.060 |
Why?
|
| Ureteral Diseases | 2 | 1981 | 63 | 0.060 |
Why?
|
| Patient Care Team | 2 | 2006 | 2526 | 0.060 |
Why?
|
| Nephrectomy | 1 | 2009 | 949 | 0.060 |
Why?
|
| Gallbladder | 2 | 1983 | 308 | 0.060 |
Why?
|
| Spinal Cord Diseases | 1 | 2006 | 293 | 0.060 |
Why?
|
| Diagnosis, Differential | 11 | 2007 | 13026 | 0.060 |
Why?
|
| Forms and Records Control | 2 | 1994 | 158 | 0.050 |
Why?
|
| Gallium Radioisotopes | 4 | 1985 | 195 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 794 | 0.050 |
Why?
|
| Blood Volume | 1 | 2005 | 546 | 0.050 |
Why?
|
| Biopsy | 2 | 2015 | 6816 | 0.050 |
Why?
|
| Physician Incentive Plans | 1 | 2004 | 164 | 0.050 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 649 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1749 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2004 | 256 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2004 | 617 | 0.050 |
Why?
|
| Anesthetics, Local | 2 | 2009 | 1005 | 0.050 |
Why?
|
| Facial Injuries | 1 | 2004 | 191 | 0.050 |
Why?
|
| Back Pain | 1 | 2006 | 547 | 0.050 |
Why?
|
| Aortography | 1 | 2004 | 422 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2007 | 13589 | 0.050 |
Why?
|
| Radiation Oncology | 1 | 2009 | 573 | 0.050 |
Why?
|
| Ferrosoferric Oxide | 1 | 2004 | 349 | 0.050 |
Why?
|
| Commerce | 1 | 2008 | 613 | 0.050 |
Why?
|
| Career Mobility | 1 | 2005 | 262 | 0.050 |
Why?
|
| Pentetic Acid | 3 | 1982 | 209 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2006 | 373 | 0.050 |
Why?
|
| Oxides | 1 | 2004 | 403 | 0.050 |
Why?
|
| Embolization, Therapeutic | 2 | 2010 | 1435 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1629 | 0.050 |
Why?
|
| Ferric Compounds | 1 | 2004 | 379 | 0.050 |
Why?
|
| Urography | 5 | 1985 | 316 | 0.050 |
Why?
|
| Gallbladder Diseases | 1 | 1983 | 139 | 0.050 |
Why?
|
| Spinal Diseases | 1 | 2006 | 563 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1005 | 0.050 |
Why?
|
| Urinary Bladder | 3 | 1989 | 1160 | 0.050 |
Why?
|
| Michigan | 3 | 1987 | 341 | 0.050 |
Why?
|
| Prevalence | 2 | 2011 | 15880 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20231 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 1377 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2008 | 2331 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2004 | 4077 | 0.050 |
Why?
|
| Financial Management, Hospital | 1 | 2000 | 70 | 0.040 |
Why?
|
| Hepatic Artery | 5 | 1985 | 232 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2012 | 1986 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2011 | 2601 | 0.040 |
Why?
|
| Hospitals, Urban | 2 | 2000 | 501 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2004 | 677 | 0.040 |
Why?
|
| Hospital Records | 1 | 2000 | 93 | 0.040 |
Why?
|
| Microcomputers | 2 | 1999 | 140 | 0.040 |
Why?
|
| Budgets | 2 | 2004 | 232 | 0.040 |
Why?
|
| Intracranial Aneurysm | 1 | 2010 | 1318 | 0.040 |
Why?
|
| Uterine Neoplasms | 1 | 2008 | 1422 | 0.040 |
Why?
|
| CD-ROM | 1 | 1999 | 24 | 0.040 |
Why?
|
| Computer Storage Devices | 1 | 1999 | 9 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 1142 | 0.040 |
Why?
|
| Myocardial Contraction | 6 | 1983 | 1527 | 0.040 |
Why?
|
| Colonic Neoplasms | 4 | 2007 | 2544 | 0.040 |
Why?
|
| Headache | 1 | 2007 | 1260 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2006 | 1256 | 0.040 |
Why?
|
| Cardiac Volume | 2 | 1982 | 197 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2003 | 556 | 0.040 |
Why?
|
| Urologic Diseases | 1 | 1981 | 247 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 1979 | 167 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 4 | 2004 | 2915 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1997 | 37 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2007 | 1553 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 14766 | 0.040 |
Why?
|
| Medicaid | 1 | 2011 | 2843 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 1950 | 0.040 |
Why?
|
| Telecommunications | 1 | 1998 | 79 | 0.040 |
Why?
|
| Time | 1 | 2019 | 546 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 663 | 0.040 |
Why?
|
| Certification | 2 | 2011 | 419 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2009 | 5952 | 0.040 |
Why?
|
| Erythrocytes | 5 | 1983 | 2422 | 0.040 |
Why?
|
| Thyroid Neoplasms | 3 | 1984 | 2360 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15965 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2003 | 881 | 0.030 |
Why?
|
| Patient Satisfaction | 2 | 2011 | 3484 | 0.030 |
Why?
|
| Heart Ventricles | 12 | 1987 | 3839 | 0.030 |
Why?
|
| Kidney Diseases | 2 | 2006 | 2102 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2014 | 1379 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1978 | 336 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 4 | 1993 | 117 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2004 | 1412 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2011 | 5103 | 0.030 |
Why?
|
| Stents | 1 | 2008 | 3204 | 0.030 |
Why?
|
| Length of Stay | 1 | 2010 | 6521 | 0.030 |
Why?
|
| Cost Savings | 2 | 1999 | 916 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1997 | 310 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1983 | 2258 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 1439 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 12096 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1981 | 792 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2011 | 3858 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 4622 | 0.030 |
Why?
|
| Community Networks | 1 | 1997 | 202 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2011 | 3197 | 0.030 |
Why?
|
| Lung | 4 | 2004 | 10090 | 0.030 |
Why?
|
| Iron | 1 | 2004 | 1813 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 1994 | 42 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 7956 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2011 | 39430 | 0.030 |
Why?
|
| Cardiomyopathies | 3 | 1985 | 2056 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2003 | 1669 | 0.030 |
Why?
|
| Isotope Labeling | 5 | 1994 | 395 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 1994 | 212 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2003 | 2528 | 0.030 |
Why?
|
| Subtraction Technique | 2 | 2007 | 519 | 0.030 |
Why?
|
| Institutional Management Teams | 1 | 1993 | 31 | 0.030 |
Why?
|
| Decision Making, Organizational | 1 | 1994 | 136 | 0.030 |
Why?
|
| Infant | 7 | 2012 | 36497 | 0.030 |
Why?
|
| Congresses as Topic | 2 | 2010 | 810 | 0.030 |
Why?
|
| Disease Management | 1 | 2004 | 2533 | 0.030 |
Why?
|
| Hospital Design and Construction | 1 | 1993 | 33 | 0.030 |
Why?
|
| Hyperaldosteronism | 5 | 1984 | 250 | 0.030 |
Why?
|
| Time Factors | 7 | 2010 | 40271 | 0.030 |
Why?
|
| Confidentiality | 1 | 1998 | 606 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 1993 | 6978 | 0.030 |
Why?
|
| Methods | 5 | 1981 | 1067 | 0.030 |
Why?
|
| Naphthalenes | 1 | 1994 | 198 | 0.030 |
Why?
|
| Thyroid Gland | 3 | 1984 | 1172 | 0.030 |
Why?
|
| Inventories, Hospital | 1 | 1992 | 4 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 1999 | 998 | 0.030 |
Why?
|
| Benzylamines | 1 | 1994 | 252 | 0.030 |
Why?
|
| Hemangioma, Cavernous | 1 | 1993 | 107 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 1994 | 565 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 2238 | 0.030 |
Why?
|
| Curriculum | 1 | 2006 | 3778 | 0.030 |
Why?
|
| Lymphatic Diseases | 2 | 1989 | 320 | 0.030 |
Why?
|
| Brain | 3 | 2018 | 27438 | 0.030 |
Why?
|
| Diuresis | 3 | 1989 | 106 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2011 | 54914 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 15460 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2005 | 8051 | 0.020 |
Why?
|
| Benchmarking | 1 | 1998 | 1058 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2268 | 0.020 |
Why?
|
| Pathology, Clinical | 1 | 1994 | 377 | 0.020 |
Why?
|
| Diphosphonates | 1 | 1976 | 635 | 0.020 |
Why?
|
| Femoral Neoplasms | 3 | 1976 | 85 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 6217 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1979 | 2611 | 0.020 |
Why?
|
| Current Procedural Terminology | 1 | 2011 | 101 | 0.020 |
Why?
|
| Liver | 2 | 1985 | 7575 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 4906 | 0.020 |
Why?
|
| Xenon Radioisotopes | 4 | 1993 | 33 | 0.020 |
Why?
|
| Myocardial Infarction | 7 | 1981 | 11515 | 0.020 |
Why?
|
| Medical Audit | 1 | 2011 | 454 | 0.020 |
Why?
|
| Adrenal Gland Diseases | 2 | 1989 | 141 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2011 | 882 | 0.020 |
Why?
|
| Laboratories | 1 | 1993 | 463 | 0.020 |
Why?
|
| Dogs | 7 | 1988 | 3847 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1978 | 1065 | 0.020 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 1989 | 91 | 0.020 |
Why?
|
| Diphosphates | 5 | 1985 | 89 | 0.020 |
Why?
|
| Adosterol | 2 | 1979 | 6 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 4 | 1993 | 1629 | 0.020 |
Why?
|
| Sterols | 2 | 1979 | 64 | 0.020 |
Why?
|
| Thallium Radioisotopes | 1 | 1989 | 139 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 1993 | 1158 | 0.020 |
Why?
|
| Captopril | 1 | 1989 | 262 | 0.020 |
Why?
|
| Breast | 1 | 1977 | 1976 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2012 | 420 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 1979 | 3472 | 0.020 |
Why?
|
| Digestive System | 1 | 1989 | 244 | 0.020 |
Why?
|
| Streptokinase | 1 | 1988 | 186 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1978 | 2929 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 1988 | 142 | 0.020 |
Why?
|
| Adenoma | 1 | 1978 | 2163 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9507 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1997 | 3783 | 0.020 |
Why?
|
| Angina Pectoris | 2 | 1982 | 960 | 0.020 |
Why?
|
| Quality Control | 2 | 2004 | 835 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1395 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2010 | 555 | 0.020 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1987 | 101 | 0.020 |
Why?
|
| Adnexal Diseases | 1 | 2007 | 105 | 0.020 |
Why?
|
| Role | 1 | 1987 | 176 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2010 | 952 | 0.020 |
Why?
|
| Clinical Chemistry Tests | 1 | 2006 | 59 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2012 | 1444 | 0.020 |
Why?
|
| Cushing Syndrome | 4 | 1984 | 241 | 0.020 |
Why?
|
| Chemistry | 1 | 1985 | 327 | 0.020 |
Why?
|
| Graves Disease | 2 | 1978 | 239 | 0.020 |
Why?
|
| Electrocardiography | 7 | 1983 | 6410 | 0.020 |
Why?
|
| Catecholamines | 2 | 1984 | 390 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 486 | 0.020 |
Why?
|
| Stroke | 1 | 2008 | 9791 | 0.020 |
Why?
|
| Cholangiography | 1 | 1985 | 182 | 0.020 |
Why?
|
| Economics, Medical | 1 | 2005 | 112 | 0.020 |
Why?
|
| Formularies as Topic | 1 | 1985 | 94 | 0.020 |
Why?
|
| Leasing, Property | 1 | 2004 | 1 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2010 | 712 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1998 | 3408 | 0.020 |
Why?
|
| Osteosarcoma | 3 | 1976 | 912 | 0.020 |
Why?
|
| Exercise Test | 3 | 1989 | 2186 | 0.020 |
Why?
|
| Pharmacokinetics | 1 | 2005 | 86 | 0.010 |
Why?
|
| Radiographic Magnification | 1 | 2004 | 18 | 0.010 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 1985 | 79 | 0.010 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2006 | 425 | 0.010 |
Why?
|
| Liver Circulation | 4 | 1985 | 159 | 0.010 |
Why?
|
| Doxorubicin | 2 | 1982 | 2229 | 0.010 |
Why?
|
| Health Services Research | 1 | 2011 | 1815 | 0.010 |
Why?
|
| Drug Implants | 1 | 1984 | 231 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 1984 | 101 | 0.010 |
Why?
|
| Dobutamine | 1 | 1984 | 116 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15638 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1983 | 63 | 0.010 |
Why?
|
| Technetium Tc 99m Disofenin | 1 | 1983 | 13 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 2 | 1983 | 1468 | 0.010 |
Why?
|
| Imino Acids | 1 | 1983 | 19 | 0.010 |
Why?
|
| Career Choice | 1 | 2010 | 769 | 0.010 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1983 | 64 | 0.010 |
Why?
|
| Coronary Artery Bypass | 3 | 1983 | 2194 | 0.010 |
Why?
|
| Systole | 2 | 1982 | 938 | 0.010 |
Why?
|
| Inpatients | 1 | 2014 | 2561 | 0.010 |
Why?
|
| Lymphedema | 1 | 1989 | 527 | 0.010 |
Why?
|
| Sick Sinus Syndrome | 1 | 1982 | 51 | 0.010 |
Why?
|
| Patient Admission | 1 | 2010 | 1370 | 0.010 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 1983 | 117 | 0.010 |
Why?
|
| Myocarditis | 2 | 1980 | 804 | 0.010 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1982 | 94 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 1984 | 485 | 0.010 |
Why?
|
| Stroke Volume | 5 | 1983 | 5620 | 0.010 |
Why?
|
| Heart Valve Diseases | 2 | 1980 | 1033 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1985 | 658 | 0.010 |
Why?
|
| Bone and Bones | 3 | 1979 | 2589 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1994 | 2913 | 0.010 |
Why?
|
| Lymph | 2 | 1979 | 78 | 0.010 |
Why?
|
| Adrenal Cortex Diseases | 1 | 1981 | 13 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1981 | 149 | 0.010 |
Why?
|
| Tissue Distribution | 4 | 1994 | 2298 | 0.010 |
Why?
|
| Aortic Valve Insufficiency | 2 | 1983 | 577 | 0.010 |
Why?
|
| Aerosols | 1 | 1984 | 637 | 0.010 |
Why?
|
| Furosemide | 1 | 1982 | 171 | 0.010 |
Why?
|
| Neoplasm Metastasis | 6 | 1979 | 4931 | 0.010 |
Why?
|
| Age Factors | 2 | 2014 | 18478 | 0.010 |
Why?
|
| Nasal Mucosa | 1 | 1984 | 412 | 0.010 |
Why?
|
| Perfusion | 1 | 1985 | 1402 | 0.010 |
Why?
|
| Fractures, Bone | 3 | 1979 | 2063 | 0.010 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1980 | 89 | 0.010 |
Why?
|
| Heparin | 1 | 1988 | 1636 | 0.010 |
Why?
|
| Common Bile Duct | 1 | 1980 | 106 | 0.010 |
Why?
|
| Kidney Calculi | 1 | 1985 | 469 | 0.010 |
Why?
|
| Ligation | 1 | 1981 | 447 | 0.010 |
Why?
|
| Aminophylline | 1 | 1980 | 41 | 0.010 |
Why?
|
| Pulmonary Heart Disease | 1 | 1980 | 34 | 0.010 |
Why?
|
| Endothelium | 1 | 1983 | 768 | 0.010 |
Why?
|
| Guanidines | 1 | 1981 | 194 | 0.010 |
Why?
|
| Abdomen, Acute | 1 | 1980 | 122 | 0.010 |
Why?
|
| Drug Hypersensitivity | 2 | 1986 | 922 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1983 | 627 | 0.010 |
Why?
|
| Cholecystitis | 1 | 1980 | 181 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1983 | 321 | 0.010 |
Why?
|
| Kidney Transplantation | 3 | 1983 | 4285 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1339 | 0.010 |
Why?
|
| Urodynamics | 1 | 1981 | 348 | 0.010 |
Why?
|
| Microspheres | 2 | 1983 | 789 | 0.010 |
Why?
|
| Coronary Care Units | 1 | 1980 | 235 | 0.010 |
Why?
|
| Kinetics | 2 | 1985 | 6348 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1983 | 649 | 0.010 |
Why?
|
| Bony Callus | 1 | 1979 | 41 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1981 | 681 | 0.010 |
Why?
|
| Spinal Cord Injuries | 1 | 2006 | 928 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1981 | 246 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2008 | 2058 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1980 | 332 | 0.010 |
Why?
|
| Pulmonary Artery | 2 | 1988 | 1949 | 0.010 |
Why?
|
| Metyrapone | 1 | 1978 | 22 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1979 | 365 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22293 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1982 | 881 | 0.010 |
Why?
|
| Propranolol | 1 | 1980 | 493 | 0.010 |
Why?
|
| Leg Ulcer | 1 | 1978 | 71 | 0.010 |
Why?
|
| Phenethylamines | 1 | 1978 | 95 | 0.010 |
Why?
|
| Pressure | 1 | 1981 | 1173 | 0.010 |
Why?
|
| Goiter | 1 | 1978 | 87 | 0.010 |
Why?
|
| Antineoplastic Agents | 4 | 1985 | 13708 | 0.010 |
Why?
|
| Sulfur | 4 | 1984 | 160 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1989 | 3590 | 0.010 |
Why?
|
| Tritium | 1 | 1978 | 707 | 0.010 |
Why?
|
| Tooth Extraction | 1 | 1979 | 229 | 0.010 |
Why?
|
| Ilium | 2 | 1975 | 155 | 0.010 |
Why?
|
| Diethylstilbestrol | 1 | 1977 | 87 | 0.010 |
Why?
|
| Catheterization | 1 | 1982 | 1431 | 0.010 |
Why?
|
| Animals | 13 | 2005 | 169418 | 0.010 |
Why?
|
| Amyloidosis | 1 | 1985 | 879 | 0.010 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 1981 | 433 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 1983 | 755 | 0.010 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 1977 | 143 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1978 | 318 | 0.010 |
Why?
|
| Esophagus | 1 | 1983 | 1045 | 0.010 |
Why?
|
| Osteoarthropathy, Secondary Hypertrophic | 1 | 1976 | 13 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1982 | 1009 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2863 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1992 | 8081 | 0.010 |
Why?
|
| Dexamethasone | 3 | 1981 | 1965 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 1318 | 0.010 |
Why?
|
| Facial Bones | 1 | 1977 | 209 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 1982 | 828 | 0.010 |
Why?
|
| Abdomen | 1 | 2002 | 1136 | 0.010 |
Why?
|
| Hyperostosis Frontalis Interna | 1 | 1976 | 3 | 0.010 |
Why?
|
| Pediatrics | 1 | 2011 | 3622 | 0.010 |
Why?
|
| Sheep | 1 | 1979 | 1451 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1977 | 289 | 0.010 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1976 | 87 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1981 | 1833 | 0.010 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 1977 | 190 | 0.010 |
Why?
|
| Mandible | 1 | 1980 | 759 | 0.010 |
Why?
|
| Osteitis Deformans | 1 | 1976 | 54 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1978 | 295 | 0.010 |
Why?
|
| Blood Circulation | 2 | 1986 | 248 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4266 | 0.010 |
Why?
|
| Cholesterol | 3 | 1981 | 2910 | 0.010 |
Why?
|
| Albumins | 1 | 1978 | 578 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1988 | 3458 | 0.010 |
Why?
|
| Artifacts | 1 | 2004 | 1927 | 0.010 |
Why?
|
| Giant Cell Tumors | 1 | 1975 | 89 | 0.010 |
Why?
|
| Tomography | 1 | 1977 | 442 | 0.010 |
Why?
|
| Osteoma, Osteoid | 1 | 1976 | 90 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 1984 | 1179 | 0.010 |
Why?
|
| Shock, Cardiogenic | 1 | 1980 | 711 | 0.010 |
Why?
|
| Myositis Ossificans | 1 | 1976 | 77 | 0.010 |
Why?
|
| Liver Abscess, Amebic | 1 | 1974 | 19 | 0.010 |
Why?
|
| Fourier Analysis | 2 | 1988 | 441 | 0.010 |
Why?
|
| Gallium | 1 | 1974 | 30 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1978 | 1502 | 0.010 |
Why?
|
| Aortic Valve | 2 | 1983 | 1968 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1975 | 289 | 0.010 |
Why?
|
| Paraproteinemias | 1 | 1977 | 254 | 0.010 |
Why?
|
| Minicomputers | 2 | 1984 | 10 | 0.010 |
Why?
|
| Breast Diseases | 1 | 1977 | 443 | 0.010 |
Why?
|
| Sodium Pertechnetate Tc 99m | 2 | 1984 | 54 | 0.010 |
Why?
|
| Osteonecrosis | 1 | 1976 | 230 | 0.010 |
Why?
|
| Ribs | 1 | 1975 | 261 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 2 | 1983 | 2032 | 0.010 |
Why?
|
| Prognosis | 2 | 2006 | 30028 | 0.010 |
Why?
|
| Floxuridine | 2 | 1984 | 44 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1992 | 23 | 0.010 |
Why?
|
| Hyperemia | 1 | 1974 | 225 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1978 | 670 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1976 | 358 | 0.010 |
Why?
|
| Adrenal Cortex | 2 | 1984 | 134 | 0.010 |
Why?
|
| Macaca mulatta | 2 | 1994 | 2363 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1983 | 2485 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 4630 | 0.010 |
Why?
|
| 3-Iodobenzylguanidine | 2 | 1984 | 115 | 0.010 |
Why?
|
| Hematoma | 1 | 1976 | 768 | 0.010 |
Why?
|
| Half-Life | 2 | 1984 | 650 | 0.010 |
Why?
|
| Social Responsibility | 1 | 1994 | 385 | 0.010 |
Why?
|
| Drug Evaluation | 2 | 1984 | 642 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1975 | 408 | 0.010 |
Why?
|
| Colloids | 3 | 1977 | 127 | 0.010 |
Why?
|
| Cysts | 1 | 1976 | 685 | 0.010 |
Why?
|
| Urinary Tract | 1 | 1974 | 305 | 0.010 |
Why?
|
| Necrosis | 1 | 1975 | 1621 | 0.010 |
Why?
|
| Shock, Septic | 1 | 1977 | 774 | 0.010 |
Why?
|
| Estrogens | 1 | 1977 | 1531 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1978 | 1818 | 0.010 |
Why?
|
| Androgens | 1 | 1978 | 1285 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1977 | 1197 | 0.010 |
Why?
|
| Skull | 1 | 1974 | 832 | 0.010 |
Why?
|
| Hemodynamics | 3 | 1986 | 4202 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1978 | 1265 | 0.010 |
Why?
|
| Tibia | 1 | 1975 | 1075 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1976 | 715 | 0.010 |
Why?
|
| Lymphoma | 1 | 1978 | 1907 | 0.010 |
Why?
|
| Pheochromocytoma | 2 | 1984 | 328 | 0.000 |
Why?
|
| Calcinosis | 1 | 1977 | 1485 | 0.000 |
Why?
|
| Kidney | 2 | 1983 | 7064 | 0.000 |
Why?
|
| Dilatation, Pathologic | 2 | 1980 | 528 | 0.000 |
Why?
|
| Myocardium | 1 | 1981 | 4788 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1977 | 1427 | 0.000 |
Why?
|
| Phenotype | 1 | 2005 | 16712 | 0.000 |
Why?
|
| Infant, Newborn | 3 | 1981 | 26395 | 0.000 |
Why?
|
| Heart Failure | 2 | 1981 | 11857 | 0.000 |
Why?
|
| Particle Size | 2 | 1984 | 1654 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1986 | 659 | 0.000 |
Why?
|
| Posture | 2 | 1979 | 956 | 0.000 |
Why?
|
| Heart Rate | 3 | 1982 | 4218 | 0.000 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 1985 | 52 | 0.000 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1984 | 63 | 0.000 |
Why?
|
| Acute Kidney Injury | 1 | 1977 | 1943 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1977 | 2489 | 0.000 |
Why?
|
| Mitomycins | 1 | 1984 | 46 | 0.000 |
Why?
|
| Iodobenzenes | 1 | 1984 | 23 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 2 | 1980 | 592 | 0.000 |
Why?
|
| Adenocarcinoma | 2 | 1982 | 6400 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1977 | 4505 | 0.000 |
Why?
|
| Erythrocyte Volume | 1 | 1983 | 28 | 0.000 |
Why?
|
| Starch | 1 | 1983 | 81 | 0.000 |
Why?
|
| Oxyquinoline | 1 | 1983 | 17 | 0.000 |
Why?
|
| Mitomycin | 1 | 1984 | 264 | 0.000 |
Why?
|
| Diatrizoate | 1 | 1982 | 81 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1988 | 2228 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1985 | 900 | 0.000 |
Why?
|
| Diatrizoate Meglumine | 1 | 1982 | 79 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 8201 | 0.000 |
Why?
|
| Carcinoid Tumor | 1 | 1984 | 226 | 0.000 |
Why?
|
| Cadaver | 2 | 1977 | 1362 | 0.000 |
Why?
|
| Occult Blood | 1 | 1983 | 199 | 0.000 |
Why?
|
| Agranulocytosis | 1 | 1982 | 98 | 0.000 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1982 | 67 | 0.000 |
Why?
|
| Rats | 2 | 1994 | 23839 | 0.000 |
Why?
|
| Collateral Circulation | 1 | 1983 | 293 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1981 | 18388 | 0.000 |
Why?
|
| Parathyroid Glands | 1 | 1984 | 522 | 0.000 |
Why?
|
| Foot | 2 | 1977 | 577 | 0.000 |
Why?
|
| Hypertension | 2 | 1981 | 8611 | 0.000 |
Why?
|
| Catheters, Indwelling | 1 | 1984 | 436 | 0.000 |
Why?
|
| Postoperative Complications | 3 | 1983 | 15880 | 0.000 |
Why?
|
| Pituitary Gland | 1 | 1984 | 634 | 0.000 |
Why?
|
| Scintillation Counting | 1 | 1981 | 36 | 0.000 |
Why?
|
| Radioactive Tracers | 1 | 1981 | 68 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 946 | 0.000 |
Why?
|
| Tachycardia | 1 | 1983 | 599 | 0.000 |
Why?
|
| Testis | 1 | 1984 | 783 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1983 | 1266 | 0.000 |
Why?
|
| Nose | 1 | 1984 | 524 | 0.000 |
Why?
|
| Recurrence | 1 | 1992 | 8510 | 0.000 |
Why?
|
| Mathematics | 1 | 1981 | 704 | 0.000 |
Why?
|
| Heart Aneurysm | 1 | 1980 | 114 | 0.000 |
Why?
|
| Cilia | 1 | 1984 | 499 | 0.000 |
Why?
|
| Microcirculation | 1 | 1984 | 1282 | 0.000 |
Why?
|
| Heart Arrest, Induced | 1 | 1981 | 361 | 0.000 |
Why?
|
| Stomatitis | 1 | 1982 | 271 | 0.000 |
Why?
|
| Ovary | 1 | 1984 | 960 | 0.000 |
Why?
|
| Acetates | 1 | 1980 | 318 | 0.000 |
Why?
|
| Pregnancy | 2 | 1978 | 30179 | 0.000 |
Why?
|
| Diastole | 1 | 1981 | 784 | 0.000 |
Why?
|
| Jaw Neoplasms | 1 | 1979 | 72 | 0.000 |
Why?
|
| Technology, Pharmaceutical | 1 | 1978 | 84 | 0.000 |
Why?
|
| Transplantation, Homologous | 2 | 1977 | 4834 | 0.000 |
Why?
|
| Cardiomegaly | 1 | 1981 | 591 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1988 | 6320 | 0.000 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 1977 | 65 | 0.000 |
Why?
|
| Americium | 1 | 1977 | 2 | 0.000 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1979 | 161 | 0.000 |
Why?
|
| Pancreas | 1 | 1984 | 1703 | 0.000 |
Why?
|
| Renal Artery Obstruction | 1 | 1977 | 218 | 0.000 |
Why?
|
| Oxygen | 1 | 1988 | 4269 | 0.000 |
Why?
|
| Syndrome | 1 | 1982 | 3278 | 0.000 |
Why?
|
| Knee | 1 | 1977 | 279 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1979 | 1154 | 0.000 |
Why?
|
| Shoulder | 1 | 1977 | 301 | 0.000 |
Why?
|
| Mediastinal Neoplasms | 1 | 1978 | 403 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1981 | 3073 | 0.000 |
Why?
|
| Pelvic Bones | 1 | 1977 | 270 | 0.000 |
Why?
|
| Urine | 1 | 1976 | 363 | 0.000 |
Why?
|
| Obesity | 1 | 1977 | 13065 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1984 | 6353 | 0.000 |
Why?
|
| Blood Pressure | 2 | 1980 | 8538 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1976 | 9182 | 0.000 |
Why?
|
| Citrates | 1 | 1974 | 134 | 0.000 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 1973 | 25 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1982 | 1183 | 0.000 |
Why?
|
| Inguinal Canal | 1 | 1973 | 71 | 0.000 |
Why?
|
| Radiotherapy | 1 | 1980 | 1510 | 0.000 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1973 | 138 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1976 | 11206 | 0.000 |
Why?
|
| Drug Compounding | 1 | 1973 | 243 | 0.000 |
Why?
|
| Hydrogen Sulfide | 1 | 1973 | 142 | 0.000 |
Why?
|
| Bayes Theorem | 1 | 1980 | 2358 | 0.000 |
Why?
|
| Lumbosacral Region | 1 | 1973 | 294 | 0.000 |
Why?
|
| Hand | 1 | 1977 | 907 | 0.000 |
Why?
|
| Hindlimb | 1 | 1973 | 516 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1978 | 2268 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1981 | 2696 | 0.000 |
Why?
|
| Sarcoma | 1 | 1982 | 1806 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1982 | 3122 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1982 | 10784 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1984 | 12450 | 0.000 |
Why?
|
| Echocardiography | 1 | 1981 | 5043 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1978 | 3734 | 0.000 |
Why?
|
| Thrombosis | 1 | 1977 | 2956 | 0.000 |
Why?
|
| Melanoma | 1 | 1982 | 5740 | 0.000 |
Why?
|